Security key
17322U207
- Security type / class
- Equity / COM
- Total 13F shares
- 14,459,613
- Total 13F value
- $16,916,114
- Share change
- +216,641
- Put/Call ratio
- 33%
- SEC-reported price per share
- $1.17
- Number of holders
- 55
- Value change
- +$339,224
- Number of buys
- 26
- Number of sells
- 18
Open additional details 1 more signal available
Report period
Q1 2023
Institutions
55
Top holders
10
CTXR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Citius Pharmaceuticals, Inc. SEC filings
Citius Pharmaceuticals, Inc. company facts
Citius Pharmaceuticals, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 17322U207
Recent filing periods:
Ownership snapshot
Top reported holders of CTXR - CITIUS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F
Highest disclosed value: $4,751,081
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $4.75M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$4.75M
BlackRock Finance, Inc.
$1.84M
GEODE CAPITAL MANAGEMENT, LLC
$1.05M
MILLENNIUM MANAGEMENT LLC
$435K
GSA CAPITAL PARTNERS LLP
$394K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$4,751,081
6,014,027 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$1,844,365
2,334,639 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$1,052,000
1,332,623 shares
|
— | 31 Dec 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$435,000
551,126 shares
|
— | 31 Dec 2022 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
—
denominator unverified
|
$394,000
498,783 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$349,652
442,597 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
55
Shares
14,459,613
Rows available
55
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2023 holders
55
Holder diff
54
| Investor | Q3 2025 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend